🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare two treatment regimes, namely...
Status
Recruiting
Location
Tata Memorial Centre
Start Date
2024-03-07
Trial ID
NCT06214572
The investigators conducted a phase II, prospective, two-arm clinical study...
Status
Unknown
Location
Fujian Medical University Union Hospital
Start Date
2023-05-25
Trial ID
NCT05821452
Treatments Being Tested
This phase II trail will evaluate the efficacy and safety of combining gemc...
Status
Recruiting
Location
Hepatobiliary Surgery Center, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University
Start Date
2024-10-24
Trial ID
NCT06591650
Treatments Being Tested
This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2026-06-16
Trial ID
NCT07629817
This study aims to observe and explore the efficacy and safety of Penpulima...
Status
Recruiting
Location
Shanghai Ninth People's Hostipal, Shanghai Jiao Tong University School of Medicine
Start Date
2023-10-30
Trial ID
NCT06081673
Treatments Being Tested
The purpose of this single arm, phase Ⅱ clinical trail is to determine the ...
Status
Unknown
Location
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Start Date
2019-02-15
Trial ID
NCT03830385
Treatments Being Tested
This study is an exploratory clinical trial to investigate the feasibility ...
Status
Recruiting
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2024-09-03
Trial ID
NCT06289751
Aumolertinib is a third-generation epidermal growth factor receptor (EGFR) ...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2022-12-14
Trial ID
NCT05493501
This is a phase II study to assess the efficacy, safety, and Health Related...
Status
Recruiting
Location
Ryan Nguyen
Start Date
2022-12-28
Trial ID
NCT05613413
Treatments Being Tested
This is a multicenter phase II clinical study to explore the efficacy, safe...
Status
Recruiting
Location
Peking University Cancer Hospital
Start Date
2025-04-30
Trial ID
NCT06869226
Treatments Being Tested